DZ Bank
SUPN icon

DZ Bank’s Supernus Pharmaceuticals SUPN Stock Holding History

DZ Bank’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Sell
39,690
-13,119
-25% -$630K ﹤0.01% 668
2026
Q1 		$2.73M Buy
52,809
+41,745
+377% +$2.13M ﹤0.01% 587
2025
Q4 		$550K Sell
11,064
-2,417
-18% -$118K ﹤0.01% 775
2025
Q3 		$644K Sell
13,481
-109,274
-89% -$4.4M ﹤0.01% 749
2025
Q2 		$3.87M Buy
+122,755
New +$3.93M ﹤0.01% 516
2025
Q1 		– Sell
-38,885
Closed -$1.41M – 1026
2024
Q4 		$1.41M Sell
38,885
-103,501
-73% -$3.64M ﹤0.01% 622
2024
Q3 		$4.44M Hold
142,386
– – ﹤0.01% 482
2024
Q2 		$3.81M Sell
142,386
-31,232
-18% -$905K ﹤0.01% 500
2024
Q1 		$5.92M Buy
+173,618
New +$5.17M 0.01% 440
2018
Q4 		– Sell
-14,632
Closed -$736K – 809
2018
Q3 		$736K Sell
14,632
-7,573
-34% -$374K ﹤0.01% 562
2018
Q2 		$1.33M Sell
22,205
-11,126
-33% -$576K ﹤0.01% 534
2018
Q1 		$1.53M Hold
33,331
– – 0.01% 589
2017
Q4 		$1.33M Buy
33,331
+2,571
+8% +$102K 0.01% 531
2017
Q3 		$1.23M Buy
30,760
+5,183
+20% +$224K 0.01% 538
2017
Q2 		$1.1M Buy
25,577
+24,417
+2,105% +$869K 0.01% 548
2017
Q1 		$36K Buy
+1,160
New +$31.1K ﹤0.01% 862

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

DZ Bank's SUPN Position: Q2 2026 in Review

DZ Bank reduced its Supernus Pharmaceuticals (SUPN) stake by 25% in Q2 2026, selling an estimated $630K and leaving 39,690 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #668.

DZ Bank first reported a position in SUPN in Q1 2017 and has held it in 16 quarters since. The position peaked at $5.92M in Q1 2024. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • DZ Bank held 39,690 shares of Supernus Pharmaceuticals worth $1.85M as of Q2 2026.
  • DZ Bank sold 13,119 Supernus Pharmaceuticals shares in Q2 2026, an estimated $630K.
  • Supernus Pharmaceuticals made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #668 holding.
  • DZ Bank first reported a position in Supernus Pharmaceuticals in Q1 2017 and has held it in 16 quarters since.
  • DZ Bank's Supernus Pharmaceuticals position peaked at $5.92M in Q1 2024.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.